Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical
empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to
others. The current study investigates differences in duration of acute effects and side
effects after administration of a single dose of MDMA compared to a repeated administration.